PAR ASX Chart
Snapshot
Paradigm Biopharmaceuticals Ltd. (PAR) is a commercially focused drug development company and is headquartered in Melbourne, Australia with offices in the EU and US.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +21.71% |
vs ASX 200 (1yr) | +20.10% |
Announcements
Corporate Overview
Corporate Details
Head Office | Melbourne VIC 3000 |
Website | www.paradigmbiopharma.com |
Registry | Automic Group |
Auditor | RSM Australia Partners |
Date Listed | 19 Aug 2015 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
26/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/08/2025 | Report (Annual) |
Former Company Names
- Paradigm Biopharmaceuticals Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
PAR directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of PAR directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Sandhurst Trustees Ltd | 14/08/2024 | 15,148,692 | 4.32 |
Citicorp Nominees Pty Limited | 14/08/2024 | 15,194,109 | 4.34 |
HSBC Custody Nominees (Australia) Limited | 14/08/2024 | 16,098,954 | 4.59 |
Paul Rennie and related companies | 14/08/2024 | 20,678,805 | 5.90 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
17-05-24 | Allianz SE and the entities | 1,093,405 | 7.09 | 6.08 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
24-09-24 | Allianz SE and the entities | 21,308,735 | 6.08 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.255 | 28 June |
2023 | $0.99 | 30 June |
2022 | $0.965 | 30 June |
2021 | $2.10 | 30 June |
2020 | $3.15 | 30 June |
2019 | $1.40 | 28 June |
2018 | $0.65 | 29 June |
2017 | $0.29 | 30 June |
2016 | $0.35 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.